Fingerprint
Dive into the research topics where Wei Qiao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemia
Kadia, T. M., Jain, A., Rausch, C. R., Bataller, A., Ravandi, F., Jabbour, E., Qiao, W., Borthakur, G., Short, N., Montalban-Bravo, G., Quesada, A. E., Burger, J., Ferrajoli, A., Wierda, W., Hosing, C. & Kantarjian, H., Feb 2026, In: Blood Neoplasia. 3, 1, 100175.Research output: Contribution to journal › Article › peer-review
Open Access -
Prescription Monitoring Program Review Among Patients with Cancer Receiving Opioids at a Safety-Net Palliative Medicine Clinic
Pacheco, S., Nguyen, L. M. T., Arthur, J. A., Manuel, C. M., Qiao, W. & Hui, D., Mar 2026, In: Cancers. 18, 5, 762.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemia
Jen, W. Y., Croden, J., Almanza-Huante, E., DiNardo, C., Chien, K., Hammond, D., Qiao, W., Alvarado, Y., Masarova, L., Quesada, A. E., Pierce, S., Bataller, A., Garcia-Manero, G., Alousi, A., Short, N., Daver, N., Ravandi, F., Kantarjian, H. & Kadia, T. M., Oct 2025, In: HemaSphere. 9, 10, e70214.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Kadia, T. M., Jen, W. Y., Bataller, A., Bazinet, A., Borthakur, G., Jabbour, E., Qiao, W., Short, N. J., Takahashi, K., Issa, G. C., DiNardo, C. D., Montalban-Bravo, G., Pemmaraju, N., Tran, A., Bharathi, V., Loghavi, S., Alousi, A. M., Popat, U., Daver, N. G. & Ravandi, F. & 1 others, , Aug 2025, In: American journal of hematology. 100, 8, p. 1365-1373 9 p.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Scopus citations -
A pilot study of lower doses of ibrutinib: patient body weight does not correlate with plasma ibrutinib levels during therapy
Chen, L. S., Bose, P., Qiao, W., Jiang, Y., Wu, Q., Cruz, N. D., Keating, M. J. & Gandhi, V., 2025, In: Leukemia and Lymphoma. 66, 6, p. 1166-1168 3 p.Research output: Contribution to journal › Letter › peer-review